Standort in Deutschland, wo man günstige und qualitativ hochwertige Kamagra Ohne Rezept Lieferung in jedem Teil der Welt zu kaufen.

Wenn das Problem der Verringerung der Potenz berührt mich persönlich war ich schockiert, dass das passiert gerade mit mir levitra Übrigens jeder leisten und gibt eine sofortige Wirkung ohne Hausarbeiten Anwendungen.

4rth summer school

7 t h S u m m e r S c h o o l o f t h e H e l l e n i c A t h e r o s c l e r o s i s S o c i e t y
Lifestyle and pharmacological interventions for the management
of cardiovascular disease: dilemmas and perspectives
June 26 – 28, 2014, Crowne Plaza Hotel, Athens, Greece
SCIENTIFIC PROGRAM
Thursday, June 26, 2014
Welcome address by the coordinators of the Summer School. E. Liberopoulos (Ioannina, Greece) – K. Tziomalos
(Thessaloniki, Greece).

Welcome address by the President of the Hellenic Atherosclerosis
Society.
E. Ganotakis (Heraklion, Greece).
Lifestyle recommendations for the primary prevention of
cardiovascular disease.
C. Kastorini (Athens, Greece).
Discussion with the participants on multiple choice questions.
Weight loss: how important and how feasible?
M. Yannakoulia (Athens, Greece).
Discussion with the participants on multiple choice questions.
The impact of diet composition in macronutrients on weight loss.
E. Bathrellou (Athens, Greece).
Discussion with the participants on multiple choice questions. Mediterranean diet as a tool for the management and prevention of cardiovascular disease. M. Kontogianni (Athens, Greece).
Discussion with the participants on multiple choice questions. Dietary management of hypertension.
Κ. Karatzi (Athens, Greece).
Discussion with the participants on multiple choice questions. Friday, June 27, 2014
Dietary targets in type 2 diabetes mellitus.
Μ. Karipidou (Athens, Greece).
Discussion with the participants on multiple choice questions.
The role of omega-3 fatty acids in the secondary and tertiary
prevention of cardiovascular disease.
P. Detopoulou (Athens, Greece).
Discussion with the participants on multiple choice questions.
The role of dietary supplements in the prevention and treatment of
cardiovascular disease.
Τ. Nomikos (Athens, Greece).
Discussion with the participants on multiple choice questions.
Bioactive nutrients with antioxidant, antithrombotic and
antiinflammatory action.
Ε. Fragopoulou (Athens, Greece).
Discussion with the participants on multiple choice questions.
Exercise recommendations in patients with cardiovascular disease:
type and intensity.
Κ. Anastasiou (Athens, Greece).
Discussion with the participants on multiple choice questions. Efficacy of comprehensive smoking cessation programs. P. Katsaounou (Athens, Greece).
Discussion with the participants on multiple choice questions.
Lipid-lowering treatment for the reduction of residual
cardiovascular risk after achieving LDL targets with a statin:
addition of fenofibrate or omega-3 fatty acids?
V. Athyros (Thessaloniki, Greece).
Discussion with the participants on multiple choice questions.
Lipid-lowering treatment in patients who do not achieve LDL
targets with the maximal tolerated dose of a potent study: addition
of ezetimibe or colesevelam?
M. Elisaf (Ioannina, Greece).
Discussion with the participants on multiple choice questions.
Antiplatelet treatment in patients with an acute coronary
syndrome: aspirin combined with clopidogrel, prasugrel or
ticagrelor?
V. Nikolaou (Athens, Greece).
Discussion with the participants on multiple choice questions.
Antiplatelet treatment in patients with a recurrent cardiovascular
treatment despite treatment with antiplatelets.
A. Tselepis (Ioannina, Greece).
Discussion with the participants on multiple choice questions.
Anticoagulant treatment in patients with atrial fibrillation: warfarin
or novel anticoagulants?
C. Pitsavos (Athens, Greece).
Discussion with the participants on multiple choice questions.
Medical research methodology.
D. Panagiotakos (Athens, Greece).
Discussion with the participants on multiple choice questions. Should we evaluate the presence of subclinical atherosclerosis in
patients without established cardiovascular disease?
Foreigner speaker (TBD).
Discussion with the participants on multiple choice questions.
Saturday, June 28, 2014
Antidiabetic treatment in patients who do not achieve HbA1c
targets despite treatment with metformin.
Α. Melidonis (Athens, Greece).
Discussion with the participants on multiple choice questions.
Intensification of insulin treatment in patients with diabetes
mellitus: basal-bolus or premixed insulin-based regimens?
S. Pappas (Athens, Greece).
Discussion with the participants on multiple choice questions.
hydrochlorothiazide, chlorthalidone or indapamide?
V. Kotsis (Thessaloniki, Greece).
Discussion with the participants on multiple choice questions.
Inhibition of renin-angiotensin-aldosterone system in patients with
hypertension: angiotensin converting enzyme inhibitors or
angiotensin receptor blockers?
A. Achimastos (Athens, Greece).
Discussion with the participants on multiple choice questions.
Antihypertensive treatment in a patient with uncontrolled
hypertension despite monotherapy with an inhibitor of the renin-
angiotensin-aldosterone system: addition of a diuretic or a calcium
channel blocker?
A. Karagiannis (Thessaloniki, Greece).
Discussion with the participants on multiple choice questions. A patient with postprandial hyperglycemia despite treatment with
basal insulin and metformin: addition of a dipeptidyl-peptidase IV
inhibitor, a glucagon-like peptide-1 analog or prandial insulin?
S. Iraklianou (Athens, Greece).
Discussion with the participants on multiple choice questions.
New anticoagulants for the treatment of deep vein thrombosis. E. Liberopoulos (Ioannina, Greece).
Discussion with the participants on multiple choice questions.
Sodium-glucose linked transporter inhibitors in the management of
type 2 diabetes mellitus.
T. Alexandridis (Patras, Greece).
Discussion with the participants on multiple choice questions.

17:15 – 17:45:
New agents in the management of hypercholesterolemia:
Cholesteryl ester transfer protein inhibitors, mipomersen and
lomitapide.
K. Tziomalos (Thessaloniki, Greece).
Discussion with the participants on multiple choice questions.
New agents in the management of hypercholesterolemia: pro-
protein convertase subtilisin kexin 9 inhibitors. Foreigner
speaker (TBD).
Discussion with the participants on multiple choice questions.
How to write a paper.
D. Mikhailidis (London, UK).
Discussion with the participants on multiple choice questions.
End of Summer School

Source: http://www.eas-society.org/fileArchive/Scientific%20Programme%20of%20the%207th%20Hellenic%20Summer%20School.pdf

27.04.2009 schweinegrippe _rki_

Einschätzung des Robert Koch-Instituts zur Situation der Schweinegrippe Stand 27.04.2009, 09:00 Uhr In den USA sind 20 Fälle von Schweine-Influenza A/H1N1 beim Menschen entdeckt worden: New York 8 Fälle, Kalifornien 7 Fälle, Texas 2 Fälle, Kansas 2 Fälle, Ohio 1 Fall. Die Symptomatik dieser Fälle ist ähnlich wie bei saisonaler Influenza; ein Patient wurde im Krankenhaus behandelt,

mdurgentcare.com

General Information - Influenza Vaccination The Disease: Influenza (flu) is caused by viruses. The fever, chills, headache, dry cough and muscle aches of flu may last from several days to more than a week, but complete recovery is usual. Certain groups of people, however, are much more likely to suffer major complications if they get the flu. People over age 65, residents of nursing hom

Copyright © 2010-2014 Internet pdf articles